Literature DB >> 32285536

Substituted adamantylphthalimides: Synthesis, antiviral and antiproliferative activity.

Leo Mandić1, Patricia Benčić2, Kata Mlinarić-Majerski1, Sandra Liekens3, Robert Snoeck3, Graciela Andrei3, Marijeta Kralj2, Nikola Basarić1.   

Abstract

In this study, three groups of adamantylphthalimides, bearing different substituents at the phthalimide moiety, N-(4'-R2 )phthalimidoadamantanes (1-7), 3-[N-(4'-R2 )phthalimido]-1-adamantanols (8-10), and 3-[N-(4'-R2 )phthalimido]adamantane-1-carboxylic acids (11-15), were synthesized and screened against tumor cells and viruses. The most potent compounds are not substituted at the adamantane and bear an OH or NH2 substituent at the phthalimide (compounds 3 and 5). The antiproliferative activities of compounds 3 and 5 are in the micromolar range, much higher than the one of thalidomide. A minor antiviral activity against cytomegalovirus and varicella-zoster virus was found for compounds 3 and 5, but these compounds lacked selectivity. The results presented are important for the rational design of the next-generation compounds with anticancer and antiviral activities.
© 2020 Deutsche Pharmazeutische Gesellschaft.

Entities:  

Keywords:  adamantane; antiproliferative activity; antiviral activity; phthalimide

Mesh:

Substances:

Year:  2020        PMID: 32285536     DOI: 10.1002/ardp.202000024

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  1 in total

1.  Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors.

Authors:  Mabrouk Horchani; Niels V Heise; René Csuk; Hichem Ben Jannet; Abdel Halim Harrath; Anis Romdhane
Journal:  Molecules       Date:  2022-08-19       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.